Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.500
0.00 (0.00%)
At close: Aug 1, 2025, 4:00 PM
1.600
+0.100 (6.67%)
Pre-market: Aug 4, 2025, 7:03 AM EDT
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $2.24 million as of August 4, 2025. Its market cap has increased by 13.38% in one year.
Market Cap
2.24M
Enterprise Value
-675.07K
1-Year Change
13.38%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $2.24M, a decrease of -96.68%. That is a compound annual growth rate of -59.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 2.24M | -16.70% |
| Dec 31, 2024 | 2.69M | 78.03% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
| Nov 10, 2021 | 67.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |